논문KCI 등재
Reply to correspondence 1 on “GOLM1 promotes cholesterol gallstone formation via ABCG5-mediated cholesterol efflux in MASH livers”
1
조회
0
다운로드
0
인용
0
참고문헌
키워드
참고문헌 (11)
관련 논문AI추천
Reply to correspondence 2 on “GOLM1 promotes cholesterol gallstone formation via ABCG5-mediated cholesterol efflux in MASH livers”Nahee Hwang, Sungsoon Fang대한간학회 · Clinical and Molecular Hepatology2025 · 제31권 제2호Correspondence to editorial on “GOLM1 promotes cholesterol gallstone formation via ABCG5-mediated cholesterol efflux in MASH livers”Jing Lin, Jin-Hong Chen, Wei-Qing Shao, Yi-Tong Li, Zhen-Mei Chen대한간학회 · Clinical and Molecular Hepatology2025 · 제31권 제2호GOLM1 and bile acid synthesis: Correspondence to editorial on “GOLM1 promotes cholesterol gallstone formation via ABCG5-mediated cholesterol efflux in MASH livers”Jing Lin, Jin-Hong Chen, Wei-Qing Shao, Yi-Tong Li, Zhen-Mei Chen대한간학회 · Clinical and Molecular Hepatology2025 · 제31권 제2호Unraveling the role of GOLM1-OPN-ABCG5 axis in MASH: Editorial on “GOLM1 promotes cholesterol gallstone formation via ABCG5-mediated cholesterol efflux in MASH livers”Seung-Jin Kim, Won Kim, Yoon-su Ha대한간학회 · Clinical and Molecular Hepatology2025 · 제31권 제2호Bridging the gap: The GOLM1-OPN-ABCG5 axis in MASH and gallstone disease: Editorial on “GOLM1 promotes cholesterol gallstone formation via ABCG5-mediated cholesterol efflux in MASH livers”Nahee Hwang, Sungsoon Fang대한간학회 · Clinical and Molecular Hepatology2025 · 제31권 제2호GOLM1 promotes cholesterol gallstone formation via ABCG5-mediated cholesterol efflux in metabolic dysfunction-associated steatohepatitis liversBao-Rui Tao, Bo Zhang, Chen-He Yi, Guo Zhang, Jing Lin, Jin-Hong Chen, Rui Zhang, Wei-Qing Shao, Xiao-Chen Ma, Yan Geng, Yi-Tong Li, Yue Ma, Zhen-Mei Chen대한간학회 · Clinical and Molecular Hepatology2025 · 제31권 제2호
이 간행물의 다른 논문 (84건)
Epidemiology of metabolic dysfunction-associated steatotic liver diseaseLinda Henry, Markos Kalligeros, Zobair M. Younossipp. 32-50Role of noninvasive tests in the prognostication of metabolic dysfunction-associated steatotic liver diseaseJimmy Che-To Lai, Sherlot Juan Song, Terry Cheuk-Fung Yip, Vincent Wai-Sun Wong, Grace Lai-Hung Wong, Yichong Jiang, Yue Wangpp. 51-75Precision medicine and nucleotide-based therapeutics to treat steatotic liver diseaseAndrea Caddeo, Stefano Romeopp. 76-93Microbiome-centered therapies for the management of metabolic dysfunction-associated steatotic liver diseaseJasmohan S. Bajaj, Jeremy Burton, Antonio Gil-Gómez, Huma Saeed, Juan Pablo Arab, Luis Antonio Díaz, Manuel Romero-Gomez, Marco Arrese, Mohammad Qasim Khanpp. 94-111Alcohol-associated liver disease: Natural history, management and novel targeted therapiesHugo López-Pelayo, Edilmar Alvarado-Tapias, Ana Clemente-Sánchez, Ramón Bataller, Jordi Gratacós-Ginès, Elisa Posepp. 112-133